InnateDB Protein
|
IDBP-22961.5
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
ERCC8
|
Protein Name
|
excision repair cross-complementing rodent repair deficiency, complementation group 8
|
Synonyms
|
CKN1; CSA; UVSS2;
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000265038
|
InnateDB Gene
|
IDBG-22959 (ERCC8)
|
Protein Structure
|
|
Function |
Substrate-recognition component of the CSA complex, a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex, involved in transcription-coupled nucleotide excision repair. The CSA complex (DCX(ERCC8) complex) promotes the ubiquitination and subsequent proteasomal degradation of ERCC6 in a UV-dependent manner; ERCC6 degradation is essential for the recovery of RNA synthesis after transcription-coupled repair. It is required for the recruitment of XAB2, HMGN1 and TCEA1/TFIIS to a transcription- coupled repair complex which removes RNA polymerase II-blocking lesions from the transcribed strand of active genes. {ECO:0000269PubMed:16751180, ECO:0000269PubMed:16916636, ECO:0000269PubMed:16964240}.
|
Subcellular Localization |
Nucleus {ECO:0000305}.
|
Disease Associations |
Cockayne syndrome A (CSA) [MIM:216400]: A rare disorder characterized by cutaneous sensitivity to sunlight, abnormal and slow growth, cachectic dwarfism, progeroid appearance, progressive pigmentary retinopathy and sensorineural deafness. There is delayed neural development and severe progressive neurologic degeneration resulting in mental retardation. Two clinical forms are recognized: in the classical form or Cockayne syndrome type 1, the symptoms are progressive and typically become apparent within the first few years or life; the less common Cockayne syndrome type 2 is characterized by more severe symptoms that manifest prenatally. Cockayne syndrome shows some overlap with certain forms of xeroderma pigmentosum. Unlike xeroderma pigmentosum, patients with Cockayne syndrome do not manifest increased freckling and other pigmentation abnormalities in the skin and have no significant increase in skin cancer. {ECO:0000269PubMed:14661080, ECO:0000269PubMed:15744458, ECO:0000269PubMed:19894250}. Note=The disease is caused by mutations affecting the gene represented in this entry.UV-sensitive syndrome 2 (UVSS2) [MIM:614621]: An autosomal recessive disorder characterized by cutaneous photosensitivity and mild freckling in the absence of neurological abnormalities or skin tumors. {ECO:0000269PubMed:19329487}. Note=The disease is caused by mutations affecting the gene represented in this entry.
|
Tissue Specificity |
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 43 experimentally validated interaction(s) in this database.
They are also associated with 10 interaction(s) predicted by orthology.
Experimentally validated |
Total |
43
[view]
|
Protein-Protein |
42
[view]
|
Protein-DNA |
1
[view]
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
Predicted by orthology |
Total |
10 [view]
|
|
|
Molecular Function |
|
Biological Process |
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR001680
WD40 repeat
IPR017986
WD40-repeat-containing domain
IPR020472
G-protein beta WD-40 repeat
|
PFAM |
PF00400
|
PRINTS |
PR00320
|
PIRSF |
|
SMART |
SM00320
|
TIGRFAMs |
|
Modification |
|
SwissProt |
Q13216
|
PhosphoSite |
PhosphoSite-Q13216
|
TrEMBL |
G3XAG7
|
UniProt Splice Variant |
|
Entrez Gene |
1161
|
UniGene |
|
RefSeq |
NP_001277214
|
HUGO |
HGNC:3439
|
OMIM |
609412
|
CCDS |
CCDS3978
|
HPRD |
07523
|
IMGT |
|
EMBL |
AC022445
AC104113
AK056931
AK314511
AY213194
BC009793
BT020021
CH471123
CR536563
U28413
|
GenPept |
AAA82605
AAH09793
AAO21128
AAV38824
BAG37111
BAG51829
CAG38800
EAW55004
EAW55005
|
|
|